SG Americas Securities
MBII

SG Americas Securities’s Marrone Bio Innovations, Inc. MBII Stock Holding History

SG Americas Securities’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,296
Closed -$10K – 3631
2021
Q4 		$10K Sell
14,296
-19,922
-58% -$16.1K ﹤0.01% 3281
2021
Q3 		$31K Buy
+34,218
New +$41.2K ﹤0.01% 3762
2020
Q3 		– Sell
-36,344
Closed -$43K – 3715
2020
Q2 		$43K Buy
36,344
+16,540
+84% +$15.3K ﹤0.01% 3556
2020
Q1 		$16K Buy
19,804
+8,748
+79% +$9.27K ﹤0.01% 3323
2019
Q4 		$11K Buy
+11,056
New +$13.4K ﹤0.01% 3177
2019
Q3 		– Sell
-39,533
Closed -$59K – 3312
2019
Q2 		$59K Sell
39,533
-9,110
-19% -$14.1K ﹤0.01% 2888
2019
Q1 		$74K Buy
+48,643
New +$74.2K ﹤0.01% 3120
2018
Q4 		– Sell
-17,491
Closed -$32K – 3427
2018
Q3 		$32K Buy
+17,491
New +$33.9K ﹤0.01% 2996
2014
Q4 		– Sell
-12,049
Closed -$32K – 3436
2014
Q3 		$32K Buy
+12,049
New +$80.5K ﹤0.01% 2540

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SG Americas Securities's MBII Position: Q1 2022 in Review

SG Americas Securities sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 14,296 shares — an estimated $10K sold.

SG Americas Securities first reported a position in MBII in Q3 2014 and held it in 9 quarters. The position peaked at $74K in Q1 2019. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • SG Americas Securities reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 14,296 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $10K.
  • SG Americas Securities first reported a position in Marrone Bio Innovations, Inc. in Q3 2014 and held it in 9 quarters.
  • SG Americas Securities's Marrone Bio Innovations, Inc. position peaked at $74K in Q1 2019.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.